Immuneering's total assets for Q3 2024 were $68.56M, a decrease of -11.07% from the previous quarter. IMRX total liabilities were $10.84M for the fiscal quarter, a 0.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.